235 participants
A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-05
- Start Date:
- 2023-08-28
- Completion:
- 2025-05-05
Conditions
- Atopic Dermatitis
- Atopic Hand Eczema
Interventions
- DRUG